This CrowdStrike Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Arrowhead Pharmaceuticals, Inc. -0.66%
CrowdStrike +0.62%
Ramaco Resources-A -1.36%
Mohawk Industries, Inc. -0.49%
Schneider National, Inc. Class B +0.50%

Arrowhead Pharmaceuticals, Inc.

ARWR

73.91

-0.66%

CrowdStrike

CRWD

448.13

+0.62%

Ramaco Resources-A

METC

13.79

-1.36%

Mohawk Industries, Inc.

MHK

107.74

-0.49%

Schneider National, Inc. Class B

SNDR

30.28

+0.50%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst Brian Lee upgraded Ramaco Resources Inc (NASDAQ:METC) from Sell to Neutral and raised the price target from $14 to $15. Ramaco Resources shares closed at $14.07 on Monday. See how other analysts view this stock.
  • Keybanc analyst Eric Heath upgraded Crowdstrike Holdings Inc (NASDAQ:CRWD) from Sector Weight to Overweight and announced a $525 price target. CrowdStrike shares closed at $433.15 on Monday. See how other analysts view this stock.
  • Morgan Stanley analyst Michael Ulz upgraded Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) from Equal-Weight to Overweight and raised the price target from $78 to $100. Arrowhead Pharma shares closed at $69.25 on Monday. See how other analysts view this stock.

Considering buying CRWD stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.